Skip to main content
Top
Published in: Inflammation 3/2020

01-06-2020 | Lichen Planus | Original Article

Study on the Role of Salivary Flora and NF-κB Inflammatory Signal Pathway in Oral Lichen Planus

Authors: Songsong Deng, Yingjie Xu, Xinxin Wang, Mengjia Liu, Lulu Li, Xixi Yu, Yiheng Wang, Yingtao Wu, Wanchun Wang, Meihua Gao, Beibei Cong

Published in: Inflammation | Issue 3/2020

Login to get access

Abstract

Oral lichen planus (OLP) is an inflammatory disease. It is believed that infection and immune dysfunction play a key role in its pathogenesis, but the specific mechanism of action remains unclear. The 16s rRNA high-throughput sequencing technique was used to analyze the microbial flora structure in the saliva of OLP patients and healthy controls. The relative abundance of Derxia, Haemophilus, and Pseudomonas in the saliva of the OLP group was lower than that of the healthy control group, but there was no significant difference in the overall structure of the microbial population. In addition, we measured the protein expression levels of toll-like receptor 4 (TLR4) and nuclear factor-kappab p65 (NF-κB p65) in the tissues of OLP patients, and found that there was a significant increase and positive correlation between them (r = 0.907, P = 0.034). The expression levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in the OLP group were consistent with those of NF-κB p65. Therefore, we believe that changes in the composition ratio of microbialflora break the original balance state of flora, promote the occurrence of immune inflammatory reaction, and then lead to the generation or aggravation of OLP disease. This discovery provides new ideas for further research on OLP initiation and immune regulation mechanism.
Literature
1.
go back to reference Baek, K., and Y. Choi. 2018. The microbiology of oral lichen planus: is microbial infection the cause of oral lichen planus? Mol Oral Microbiol 33: 22–28.PubMedCrossRef Baek, K., and Y. Choi. 2018. The microbiology of oral lichen planus: is microbial infection the cause of oral lichen planus? Mol Oral Microbiol 33: 22–28.PubMedCrossRef
2.
go back to reference Masaki, M., T. Sato, Y. Sugawara, T. Sasano, and N. Takahashi. 2011. Detection and identification of non-Candida albicans species in human oral lichen planus. Microbiol Immunol 55: 66–70.PubMedCrossRef Masaki, M., T. Sato, Y. Sugawara, T. Sasano, and N. Takahashi. 2011. Detection and identification of non-Candida albicans species in human oral lichen planus. Microbiol Immunol 55: 66–70.PubMedCrossRef
3.
go back to reference Tao, X.A., J. Xia, X.B. Chen, H. Wang, Y.H. Dai, N.L. Rhodus, and B. Cheng. 2010. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16: 76–82.PubMedCrossRef Tao, X.A., J. Xia, X.B. Chen, H. Wang, Y.H. Dai, N.L. Rhodus, and B. Cheng. 2010. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16: 76–82.PubMedCrossRef
4.
go back to reference Pekiner, F.N., G.Y. Demirel, M.O. Borahan, and S. Ozbayrak. 2012. Cytokine profiles in serum of patients with oral lichen planus. Cytokine 60: 701–706.PubMedCrossRef Pekiner, F.N., G.Y. Demirel, M.O. Borahan, and S. Ozbayrak. 2012. Cytokine profiles in serum of patients with oral lichen planus. Cytokine 60: 701–706.PubMedCrossRef
5.
go back to reference Axell, T., and L. Rundquist. 1987. Oral lichen planus--a demographic study. Community Dent Oral Epidemiol 15: 52–56.PubMedCrossRef Axell, T., and L. Rundquist. 1987. Oral lichen planus--a demographic study. Community Dent Oral Epidemiol 15: 52–56.PubMedCrossRef
6.
7.
go back to reference Olson, M.A., R.S. Rogers 3rd, and A.J. Bruce. 2016. Oral lichen planus. Clin Dermatol 34: 495–504.PubMedCrossRef Olson, M.A., R.S. Rogers 3rd, and A.J. Bruce. 2016. Oral lichen planus. Clin Dermatol 34: 495–504.PubMedCrossRef
8.
go back to reference Alrashdan, M.S., N. Cirillo, and M. McCullough. 2016. Oral lichen planus: a literature review and update. Arch Dermatol Res 308: 539–551.PubMedCrossRef Alrashdan, M.S., N. Cirillo, and M. McCullough. 2016. Oral lichen planus: a literature review and update. Arch Dermatol Res 308: 539–551.PubMedCrossRef
9.
go back to reference Lu, R., J. Zhang, W. Sun, G. Du, and G. Zhou. 2015. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med 44: 1–14.PubMedCrossRef Lu, R., J. Zhang, W. Sun, G. Du, and G. Zhou. 2015. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med 44: 1–14.PubMedCrossRef
10.
go back to reference Azab, N.A., L. Abd El Salam, E. Ahmed, M. El Sharkawy, A. ElSharkawy, and S.G. El Asheiry. 2018. Interferon gamma and interleukin 8 gene polymorphisms in patients with hepatitis C virus related oral lichen planus. Arch Oral Biol 96: 189–194.PubMedCrossRef Azab, N.A., L. Abd El Salam, E. Ahmed, M. El Sharkawy, A. ElSharkawy, and S.G. El Asheiry. 2018. Interferon gamma and interleukin 8 gene polymorphisms in patients with hepatitis C virus related oral lichen planus. Arch Oral Biol 96: 189–194.PubMedCrossRef
11.
go back to reference Arora, S., M. Verma, S.R. Gupta, A.B. Urs, M.S. Dhakad, and R. Kaur. 2016. Phenotypic variability and therapeutic implications of Candida species in patients with oral lichen planus. Biotech Histochem 91: 237–241.PubMedCrossRef Arora, S., M. Verma, S.R. Gupta, A.B. Urs, M.S. Dhakad, and R. Kaur. 2016. Phenotypic variability and therapeutic implications of Candida species in patients with oral lichen planus. Biotech Histochem 91: 237–241.PubMedCrossRef
12.
go back to reference Aas, J.A., B.J. Paster, L.N. Stokes, I. Olsen, and F.E. Dewhirst. 2005. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721–5732.PubMedPubMedCentralCrossRef Aas, J.A., B.J. Paster, L.N. Stokes, I. Olsen, and F.E. Dewhirst. 2005. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721–5732.PubMedPubMedCentralCrossRef
13.
go back to reference Hanamsagar, R., M.L. Hanke, and T. Kielian. 2012. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol 33: 333–342.PubMedPubMedCentralCrossRef Hanamsagar, R., M.L. Hanke, and T. Kielian. 2012. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol 33: 333–342.PubMedPubMedCentralCrossRef
14.
15.
go back to reference Kucharczak, J., M.J. Simmons, Y. Fan, and C. Gelinas. 2003. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961–8982.PubMedCrossRef Kucharczak, J., M.J. Simmons, Y. Fan, and C. Gelinas. 2003. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961–8982.PubMedCrossRef
17.
go back to reference Kim, Y.J., E.R. Jang, J.C. Lee, S.J. Seo, M.W. Lee, and C.S. Lee. 2010. Diarylheptanoid hirsutenoxime inhibits toll-like receptor 4-mediated NF-kappaB activation regulated by Akt pathway in keratinocytes. The American Journal of Chinese Medicine 38: 1207–1222.PubMedCrossRef Kim, Y.J., E.R. Jang, J.C. Lee, S.J. Seo, M.W. Lee, and C.S. Lee. 2010. Diarylheptanoid hirsutenoxime inhibits toll-like receptor 4-mediated NF-kappaB activation regulated by Akt pathway in keratinocytes. The American Journal of Chinese Medicine 38: 1207–1222.PubMedCrossRef
18.
go back to reference Piboonniyom, S.O., N. Treister, W. Pitiphat, and S.B. Woo. 2005. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 696–703.PubMedCrossRef Piboonniyom, S.O., N. Treister, W. Pitiphat, and S.B. Woo. 2005. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 696–703.PubMedCrossRef
19.
go back to reference Navazesh, M. 1993. Methods for collecting saliva. Ann N Y Acad Sci 694: 72–77. Navazesh, M. 1993. Methods for collecting saliva. Ann N Y Acad Sci 694: 72–77.
20.
go back to reference Canto, A.M., H. Muller, R.R. Freitas, and P.S. Santos. 2010. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol 85: 669–675.PubMedCrossRef Canto, A.M., H. Muller, R.R. Freitas, and P.S. Santos. 2010. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol 85: 669–675.PubMedCrossRef
21.
go back to reference Wang, L., Y. Yang, X. Xiong, T. Yu, X. Wang, W. Meng, H. Wang, G. Luo, and L. Ge. 2018. Oral lichen-planus-associated fibroblasts acquire myofibroblast characteristics and secrete pro-inflammatory cytokines in response to Porphyromonas gingivalis lipopolysaccharide stimulation. BMC Oral Health 18: 197.PubMedPubMedCentralCrossRef Wang, L., Y. Yang, X. Xiong, T. Yu, X. Wang, W. Meng, H. Wang, G. Luo, and L. Ge. 2018. Oral lichen-planus-associated fibroblasts acquire myofibroblast characteristics and secrete pro-inflammatory cytokines in response to Porphyromonas gingivalis lipopolysaccharide stimulation. BMC Oral Health 18: 197.PubMedPubMedCentralCrossRef
22.
go back to reference Andreasen, J.O. 1968. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surgery, Oral Medicine, and Oral Pathology 25: 31–42.PubMedCrossRef Andreasen, J.O. 1968. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surgery, Oral Medicine, and Oral Pathology 25: 31–42.PubMedCrossRef
23.
go back to reference Lodi, G., C. Scully, M. Carrozzo, M. Griffiths, P.B. Sugerman, and K. Thongprasom. 2005. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 40–51.PubMedCrossRef Lodi, G., C. Scully, M. Carrozzo, M. Griffiths, P.B. Sugerman, and K. Thongprasom. 2005. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 40–51.PubMedCrossRef
24.
go back to reference Hijazi, K., T. Lowe, C. Meharg, S.H. Berry, J. Foley, and G.L. Hold. 2015. Mucosal microbiome in patients with recurrent aphthous stomatitis. J Dent Res 94: 87s–94s.PubMedPubMedCentralCrossRef Hijazi, K., T. Lowe, C. Meharg, S.H. Berry, J. Foley, and G.L. Hold. 2015. Mucosal microbiome in patients with recurrent aphthous stomatitis. J Dent Res 94: 87s–94s.PubMedPubMedCentralCrossRef
26.
go back to reference Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85: 85–95.PubMedCrossRef Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85: 85–95.PubMedCrossRef
27.
go back to reference Rakoff-Nahoum, S., and R. Medzhitov. 2009. Toll-like receptors and cancer. Nat Rev Cancer 9: 57–63.PubMedCrossRef Rakoff-Nahoum, S., and R. Medzhitov. 2009. Toll-like receptors and cancer. Nat Rev Cancer 9: 57–63.PubMedCrossRef
28.
go back to reference Rusanen, P., E. Marttila, J. Uittamo, J. Hagstrom, T. Salo, and R. Rautemaa-Richardson. 2017. TLR1-10, NF-kappaB and p53 expression is increased in oral lichenoid disease. PLoS One 12: e0181361.PubMedPubMedCentralCrossRef Rusanen, P., E. Marttila, J. Uittamo, J. Hagstrom, T. Salo, and R. Rautemaa-Richardson. 2017. TLR1-10, NF-kappaB and p53 expression is increased in oral lichenoid disease. PLoS One 12: e0181361.PubMedPubMedCentralCrossRef
29.
go back to reference Siponen, M., J.H. Kauppila, Y. Soini, and T. Salo. 2012. TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med 41: 741–747.PubMedCrossRef Siponen, M., J.H. Kauppila, Y. Soini, and T. Salo. 2012. TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med 41: 741–747.PubMedCrossRef
30.
go back to reference Pahwa, R., S. Devaraj, and I. Jialal. 2016. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes. Int J Obes 40: 907–911.CrossRef Pahwa, R., S. Devaraj, and I. Jialal. 2016. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes. Int J Obes 40: 907–911.CrossRef
32.
go back to reference Martin, Guilliams, Mildner Alexander, and J. Yona Simon. 2018. Developmental and functional heterogeneity of monocytes. Immunity 49: 595–613.CrossRef Martin, Guilliams, Mildner Alexander, and J. Yona Simon. 2018. Developmental and functional heterogeneity of monocytes. Immunity 49: 595–613.CrossRef
33.
go back to reference Sheel, M., and C.R. Engwerda. 2012. The diverse roles of monocytes in inflammation caused by protozoan parasitic diseases. Trends Parasitol 28: 408–416.PubMedCrossRef Sheel, M., and C.R. Engwerda. 2012. The diverse roles of monocytes in inflammation caused by protozoan parasitic diseases. Trends Parasitol 28: 408–416.PubMedCrossRef
34.
go back to reference Gu, G.J., S.I. Ahn, J.S. Kim, C.Y. Hong, S.C. Lee, Y.T. Chang, T.H. Choi, B.S. Kim, and H.S. Youn. 2015. Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages. Int Immunopharmacol 28: 29–33.PubMedCrossRef Gu, G.J., S.I. Ahn, J.S. Kim, C.Y. Hong, S.C. Lee, Y.T. Chang, T.H. Choi, B.S. Kim, and H.S. Youn. 2015. Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages. Int Immunopharmacol 28: 29–33.PubMedCrossRef
35.
go back to reference Yoshimura, Y., and A. Barua. 2017. Female reproductive system and immunology. Adv Exp Med Biol 1001: 33–57.PubMedCrossRef Yoshimura, Y., and A. Barua. 2017. Female reproductive system and immunology. Adv Exp Med Biol 1001: 33–57.PubMedCrossRef
36.
go back to reference Cheng, L., Z. Zhang, G. Li, F. Li, L. Wang, L. Zhang, S.M. Zurawski, G. Zurawski, Y. Levy, and L. Su. 2017. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. Vaccine 35: 6143–6153.PubMedPubMedCentralCrossRef Cheng, L., Z. Zhang, G. Li, F. Li, L. Wang, L. Zhang, S.M. Zurawski, G. Zurawski, Y. Levy, and L. Su. 2017. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. Vaccine 35: 6143–6153.PubMedPubMedCentralCrossRef
37.
go back to reference Wang, Y., H. Zhang, G. Du, Y. Wang, T. Cao, Q. Luo, J. Chen, F. Chen, and G. Tang. 2016. Total glucosides of paeony (TGP) inhibits the production of inflammatory cytokines in oral lichen planus by suppressing the NF-kappaB signaling pathway. Int Immunopharmacol 36: 67–72.PubMedCrossRef Wang, Y., H. Zhang, G. Du, Y. Wang, T. Cao, Q. Luo, J. Chen, F. Chen, and G. Tang. 2016. Total glucosides of paeony (TGP) inhibits the production of inflammatory cytokines in oral lichen planus by suppressing the NF-kappaB signaling pathway. Int Immunopharmacol 36: 67–72.PubMedCrossRef
38.
go back to reference Carmody, R.J., and Y.H. Chen. 2007. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4: 31–41.PubMed Carmody, R.J., and Y.H. Chen. 2007. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4: 31–41.PubMed
39.
go back to reference Rhodus, N.L., B. Cheng, S. Myers, W. Bowles, V. Ho, and F. Ondrey. 2005. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114: 278–283.PubMedCrossRef Rhodus, N.L., B. Cheng, S. Myers, W. Bowles, V. Ho, and F. Ondrey. 2005. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114: 278–283.PubMedCrossRef
40.
go back to reference Zhao, H., Q. Zheng, X. Hu, H. Shen, and F. Li. 2016. Betulin attenuates kidney injury in septic rats through inhibiting TLR4/NF-kappaB signaling pathway. Life Sci 144: 185–193.PubMedCrossRef Zhao, H., Q. Zheng, X. Hu, H. Shen, and F. Li. 2016. Betulin attenuates kidney injury in septic rats through inhibiting TLR4/NF-kappaB signaling pathway. Life Sci 144: 185–193.PubMedCrossRef
41.
go back to reference Perkins, N.D. 2012. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121–132.PubMedCrossRef Perkins, N.D. 2012. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121–132.PubMedCrossRef
42.
go back to reference Wullaert, A., M.C. Bonnet, and M. Pasparakis. 2011. NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 21: 146–158.PubMedCrossRef Wullaert, A., M.C. Bonnet, and M. Pasparakis. 2011. NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 21: 146–158.PubMedCrossRef
43.
go back to reference Rhodus, N.L., B. Cheng, S. Myers, L. Miller, V. Ho, and F. Ondrey. 2005. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44: 77–82.PubMedCrossRef Rhodus, N.L., B. Cheng, S. Myers, L. Miller, V. Ho, and F. Ondrey. 2005. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44: 77–82.PubMedCrossRef
44.
go back to reference Crowe, A., N.S. Ding, E. Yong, H. Sheorey, M.J. Waters, and J. Daffy. 2014. Rothia aeria mitral valve endocarditis complicated by multiple mycotic aneurysms: laboratory identification expedited using MALDI-TOF MS. Infection 42: 419–423.PubMedCrossRef Crowe, A., N.S. Ding, E. Yong, H. Sheorey, M.J. Waters, and J. Daffy. 2014. Rothia aeria mitral valve endocarditis complicated by multiple mycotic aneurysms: laboratory identification expedited using MALDI-TOF MS. Infection 42: 419–423.PubMedCrossRef
Metadata
Title
Study on the Role of Salivary Flora and NF-κB Inflammatory Signal Pathway in Oral Lichen Planus
Authors
Songsong Deng
Yingjie Xu
Xinxin Wang
Mengjia Liu
Lulu Li
Xixi Yu
Yiheng Wang
Yingtao Wu
Wanchun Wang
Meihua Gao
Beibei Cong
Publication date
01-06-2020
Publisher
Springer US
Published in
Inflammation / Issue 3/2020
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-020-01185-1

Other articles of this Issue 3/2020

Inflammation 3/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.